Bryant R England1, Benedict K Tiong2, Martin J Bergman3, Jeffrey R Curtis4, Salahuddin Kazi5, Ted R Mikuls1, James R O'Dell1, Veena K Ranganath2, Alex Limanni6, Lisa G Suter7, Kaleb Michaud8. 1. VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha. 2. University of California, Los Angeles. 3. Drexel University, Philadelphia, Pennsylvania. 4. University of Alabama at Birmingham. 5. University of Texas Southwestern, Dallas. 6. Arthritis Centers of Texas, Dallas. 7. Yale University, New Haven, Connecticut, and VA Medical Center, West Haven, Connecticut. 8. University of Nebraska Medical Center, Omaha, and FORWARD, the National Databank for Rheumatic Diseases, Wichita, Kansas.
Abstract
OBJECTIVE: To provide updated American College of Rheumatology (ACR) recommendations on rheumatoid arthritis (RA) disease activity measurements to facilitate a treat-to-target approach in routine clinical care. METHODS: A working group conducted a systematic literature review from the time of the prior ACR recommendations literature search. Properties of disease activity measures were abstracted, and study quality was assessed using the Consensus-Based Standards for the selection of Health Measurement Instruments 4-point scoring method, allowing for overall level of evidence assessment. Measures that fulfilled a minimum standard were identified, and through a modified Delphi process preferred measures were selected for regular use in most clinic settings. RESULTS: The search identified 5,199 articles, of which 110 were included in the review. This search identified 46 RA disease activity measures that contained patient, provider, laboratory, and/or imaging data. Descriptions of the measures, properties, study quality, level of evidence, and feasibility were abstracted and scored. Following a modified Delphi process, 11 measures fulfilled a minimum standard for regular use in most clinic settings, and 5 measures were recommended: the Disease Activity Score in 28 Joints with Erythrocyte Sedimentation Rate or C-Reactive Protein Level, Clinical Disease Activity Index, Simplified Disease Activity Index, Routine Assessment of Patient Index Data 3, and Patient Activity Scale-II. CONCLUSION: We have updated prior ACR recommendations for preferred RA disease activity measures, identifying 11 measures that met a minimum standard for regular use and 5 measures that were preferred for regular use in most clinic settings.
OBJECTIVE: To provide updated American College of Rheumatology (ACR) recommendations on rheumatoid arthritis (RA) disease activity measurements to facilitate a treat-to-target approach in routine clinical care. METHODS: A working group conducted a systematic literature review from the time of the prior ACR recommendations literature search. Properties of disease activity measures were abstracted, and study quality was assessed using the Consensus-Based Standards for the selection of Health Measurement Instruments 4-point scoring method, allowing for overall level of evidence assessment. Measures that fulfilled a minimum standard were identified, and through a modified Delphi process preferred measures were selected for regular use in most clinic settings. RESULTS: The search identified 5,199 articles, of which 110 were included in the review. This search identified 46 RA disease activity measures that contained patient, provider, laboratory, and/or imaging data. Descriptions of the measures, properties, study quality, level of evidence, and feasibility were abstracted and scored. Following a modified Delphi process, 11 measures fulfilled a minimum standard for regular use in most clinic settings, and 5 measures were recommended: the Disease Activity Score in 28 Joints with Erythrocyte Sedimentation Rate or C-Reactive Protein Level, Clinical Disease Activity Index, Simplified Disease Activity Index, Routine Assessment of Patient Index Data 3, and Patient Activity Scale-II. CONCLUSION: We have updated prior ACR recommendations for preferred RA disease activity measures, identifying 11 measures that met a minimum standard for regular use and 5 measures that were preferred for regular use in most clinic settings.
Authors: Lidwine B Mokkink; Caroline B Terwee; Donald L Patrick; Jordi Alonso; Paul W Stratford; Dirk L Knol; Lex M Bouter; Henrica C W de Vet Journal: J Clin Epidemiol Date: 2010-07 Impact factor: 6.437
Authors: Marije F Bakker; Johannes W G Jacobs; Aike A Kruize; Maaike J van der Veen; Catharina van Booma-Frankfort; Simone A Vreugdenhil; Johannes W J Bijlsma; Floris P J G Lafeber; Paco M J Welsing Journal: Ann Rheum Dis Date: 2011-11-29 Impact factor: 19.103
Authors: Lidwine B Mokkink; Caroline B Terwee; Donald L Patrick; Jordi Alonso; Paul W Stratford; Dirk L Knol; Lex M Bouter; Henrica C W de Vet Journal: Qual Life Res Date: 2010-02-19 Impact factor: 4.147
Authors: Charlotte Vrijman; May W Linthorst Homan; Jacqueline Limpens; Wietze van der Veen; Albert Wolkerstorfer; Caroline B Terwee; Phyllis I Spuls Journal: Arch Dermatol Date: 2012-11
Authors: Cécile L Overman; Maud S Jurgens; Ercolie R Bossema; Johannes W G Jacobs; Johannes W J Bijlsma; Rinie Geenen Journal: Arthritis Care Res (Hoboken) Date: 2014-05 Impact factor: 4.794
Authors: Claire E H Barber; JoAnn Zell; Jinoos Yazdany; Aileen M Davis; Laura Cappelli; Linda Ehrlich-Jones; Donna Everix; J Carter Thorne; Victoria Bohm; Lisa Suter; Alex Limanni; Kaleb Michaud Journal: Arthritis Care Res (Hoboken) Date: 2019-11-11 Impact factor: 4.794
Authors: Katherine D Wysham; Jane Shofer; Gabriella Lui; Laura Trupin; James S Andrews; Dennis M Black; Jonathan Graf; Dolores M Shoback; Patricia P Katz Journal: Semin Arthritis Rheum Date: 2022-01-31 Impact factor: 5.532
Authors: Louise M Thoma; Rebecca J Cleveland; Beth L Jonas; S Louis Bridges; Leigh F Callahan Journal: Arthritis Care Res (Hoboken) Date: 2022-01 Impact factor: 4.794
Authors: Liana Fraenkel; Joan M Bathon; Bryant R England; E William St Clair; Thurayya Arayssi; Kristine Carandang; Kevin D Deane; Mark Genovese; Kent Kwas Huston; Gail Kerr; Joel Kremer; Mary C Nakamura; Linda A Russell; Jasvinder A Singh; Benjamin J Smith; Jeffrey A Sparks; Shilpa Venkatachalam; Michael E Weinblatt; Mounir Al-Gibbawi; Joshua F Baker; Kamil E Barbour; Jennifer L Barton; Laura Cappelli; Fatimah Chamseddine; Michael George; Sindhu R Johnson; Lara Kahale; Basil S Karam; Assem M Khamis; Iris Navarro-Millán; Reza Mirza; Pascale Schwab; Namrata Singh; Marat Turgunbaev; Amy S Turner; Sally Yaacoub; Elie A Akl Journal: Arthritis Care Res (Hoboken) Date: 2021-06-08 Impact factor: 5.178
Authors: Brent A Luedders; Tate M Johnson; Harlan Sayles; Geoffrey M Thiele; Ted R Mikuls; James R O'Dell; Bryant R England Journal: Semin Arthritis Rheum Date: 2020-06-17 Impact factor: 5.532
Authors: Pedro Santos-Moreno; Nelson J Alvis-Zakzuk; Edwin Castillo; Laura Villarreal; Carlos Pineda; Hugo Sandoval; Omaira Valencia Journal: Clinicoecon Outcomes Res Date: 2021-06-16